February 03. 2023
Inhibikase Therapeutics Inc S-1

Inhibikase Therapeutics Inc, which is in the Biological Products (No Diagnostic Substances) [2836] industry, SEC S-1 filing on February 02, 2023 had 73116 (cleaned) words - 600 were utilized for the visualizations.
Top Words:
- may - 968 instances
- product - 744 instances
- company - 678 instances
- clinical - 595 instances
- stock - 570 instances
See the parsed data used in the visualization here.
View the actual filing on the SEC website here